Mehmet Sanser Ates

Mehmet Sanser Ates

Auto-generated profile, based on publicly available information

Mehmet Sanser Ates

Department of Cardiovascular Surgery, Koç University Faculty of Medicine, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Surgery Today
Verified
Journal Article
Closed access
PDF file
NENevzat Erdil
Nevzat Erdil
SASanser Ates
Sanser Ates
LCLevent Cetin
Levent Cetin
UDUfuk Demirkilic
Ufuk Demirkilic
ESErol Sener
Erol Sener
HTHarun Tatar
Harun Tatar

1 May 2008 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MKMurat Kurtoglu
Murat Kurtoglu
SASanser Ates
Sanser Ates
TDTuba Demirozü
Tuba Demirozü
IDİbRahim Duvan
İbRahim Duvan
HKHaldun Y. Karagoz
Haldun Y. Karagoz
TATayfun Aybek
Tayfun Aybek

1 December 1999 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
ASAli Sarigül
Ali Sarigül
BFBora Farsak
Bora Farsak
MAM Şanser Ateş
M Şanser Ateş
MDMetin Demircin
Metin Demircin
İPİlhan Paşaoğlu
İlhan Paşaoğlu
Subxiphoid pericardiotomy was the primary treatment in 305 patients with pericardial effusion from January 1984 to June 1996. There were 198 males and 107 females, ages ranged from 15 days to 75 years. The procedure was carried out with local anesthesia and sedation in 263 (86.2%) patients and under general anesthesia in 42 (13.8%). Median drainage was 975.25 ± 48.46 mL in 264 patients with benign effusion and 1131.25 ± 97.48 mL in 41 (13.4%) with malignant disease; cytology was positive in 14 of 38 (36.8%) and pericardial biopsy showed cancer in 12 of 36 (33.3%). Intraoperative complications in 22 patients (7.2%) included cardiac arrest in 12 (3.9%) of whom, 7 (2.3%) died. Overall 30-day mortality was 16.3%; it was 46.3% (19/41) in malignant cases versus 11.7% (31/264) in cases of benign effusion. Follow-up of 234 (91.8%) hospital survivors for 18 ± 3.62 months (range, 2 to 54 months) showed recurrent pericardial effusion needing further intervention in 31 (13.2%) of whom, 8 had cancer and 23 had benign disease. Median survival in benign cases was more than 107 days versus 56 days in malignant cases. Because of its acceptable mortality and morbidity, subxiphoid pericardiotomy is recommend as an initial procedure.

13 October 2020 in Cardiovascular Engineering and Technology
Verified
Journal Article
Closed access
PDF file
MRMohammad Rezaeimoghaddam
Mohammad Rezaeimoghaddam
GOGokce Nur Oguz
Gokce Nur Oguz
MAMehmet Sanser Ates
Mehmet Sanser Ates
TBTijen Alkan Bozkaya
Tijen Alkan Bozkaya
SPSenol Piskin
Senol Piskin
KPKerem Pekkan
Kerem Pekkan

1 January 2016 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
IDIbrahim Duvan
Ibrahim Duvan
MAMehmet Sanser Ates
Mehmet Sanser Ates
BOBurak Emre Onuk
Burak Emre Onuk
BBBeyhan Bakkaloglu
Beyhan Bakkaloglu
USUmit Pinar Sungur
Umit Pinar Sungur
YKYahya Halidun Karagoz
Yahya Halidun Karagoz
Duvan I, et al. Korean Circ J. 2016 Jul;46(4):556-561. http://dx.doi.org/10.4070/kcj.2016.46.4.556

1 February 1999 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
ÜEÜnsal Ersoy
Ünsal Ersoy
İPİlhan Paşaoğlu
İlhan Paşaoğlu
MYMustafa Yilmaz
Mustafa Yilmaz
ŞAŞanser Ateş
Şanser Ateş
In case of aortic periprosthetic leakage, there are several methods of repair. When valve replacement or refixation is not suitable an alternative repair technique, ‘curtaining’ with a Dacron patch to prevent leakage is presented.